Capecitabine (Xeloda™) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma
- Resource Type
- Article
- Source
- In
European Journal of Cancer March 2001 37(5):597-604 - Subject
- Language
- ISSN
- 0959-8049